NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund

INVEST VIA NRE/NRO

Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth for NRI [11.13]

Min Investment

100

Fund Size

177.97 Cr

Expense Ratio

0.5%

Exit Load

0.1%

SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671

11.13

0.02%

NAV as on 01 May 24, 12:00 AM

moderate risk

index funds fixed income

debt

NAV as on 01 May 24, 12:00 AM

moderate risk

index funds fixed income

debt

6.36%p.a.

Last 1Y

0.00%p.a.

Last 3Y

0.00%p.a.

Last 5Y

7.87%p.a.

Since Inception

About Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth for NRIs

NRIs can achieve long-term capital appreciation by investing in the Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth scheme from Edelweiss Asset Management Limited. It is a Index Funds - Fixed Income mutual fund scheme that predominantly invests in Index Funds - Fixed Income stocks of companies. Launched on Nov 2022, Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth is Index Funds - Fixed Income fund of its category with 177.97 Cr fund under management as on Apr 2024. The expense ratio of this fund is less than that of most other Fund category Index Funds - Fixed Income funds.

  • Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth delivered 6.4% annual returns during the last year. It has delivered 7.9% average annual returns since the fund was launched.
  • Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
  • The scheme has predominantly invested in debt

Fund Objective

The investment objective of the scheme is to replicate CRISIL IBX 50:50 Gilt Plus SDL Index – Sep 2028 by investing in Indian Government Bonds and SDLs, maturing on or before September 28, 2028, subject to tracking errors.

Top 9 Holdings

08.47 GJ Sdl 2028

29.17%

7.06% Govt Stock 2028

28.82%

08.15 Tn SDL 2028

11.52%

7.17% Govt Stock 2028

11.23%

08.03 KA Sdl 2028

5.73%

08.79 GJ Sdl 2028

2.95%

08.16 RJ Sdl 2028

2.88%

6.13% Govt Stock 2028

2.70%

7.38% Govt Stock 2027

2.26%

Fund Managers

  1. Dhawal Dalal (Nov 2022 - Present)
  2. Rahul Dedhia (Nov 2022 - Present)

Key Information

View Scheme Document

Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth SIP Calculator

If invested

5,000

per month

For a period of

Investment of 0 could have been

0(+0.0%)

0 (+0.0%)

This Fund

0 (+0.0%)

Fixed Deposit

NRI Mutual Fund Tax on Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth

Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.

Fund TypeShort-term Capital Gains (STCG) TaxLong-term Capital Gains (LTCG) Tax
Equity mutual funds15%10% (above Rs. 1 lakh LTCG) without indexation*
Debt & other types of fundsAt tax slab rate20% with indexation benefits

How can NRIs invest in Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth?

NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:

  • Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
  • PAN Number
  • Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
  • Passport – front and back
  • Passport size photograph
  • signature

If all details are correct, your KYC will be approved within 7 to 8 business days.

  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Growth
  • Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
  • City and country of birth
  • NRE/NRO bank account statement/ canceled cheque for the latest 3 months
  • Nominee details

Frequently Asked Questions